Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023)
Avalo Therapeutics (AVTX) reported Change in Inventory of -$18000.0 for Q3 2023, down 1700.0% on a YoY basis from $1125.0 in Q3 2022, and down 1700.0% quarter-over-quarter from -$1000.0 in Q2 2023.
Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023) Analysis & Trends
Avalo Therapeutics has reported Change in Inventory for 7 years, with the latest figure at -$18000.0 in Q3 2023.
- For the quarter ending Q3 2023, Change in Inventory fell 1700.0% year-over-year to -$18000.0; the trailing twelve-month figure through Jun 2024 stood at -$18000.0 (down 260.0% YoY), and the FY2023 full-year result was -$20000.0, down 11.11% from the prior year.
- Change in Inventory for Q3 2023 stood at -$18000.0, down from -$1000.0 in the prior quarter.
- The five-year high for Change in Inventory was $68294.0 in Q4 2019, with the low at -$411736.0 in Q2 2019.
- Historically, Change in Inventory has averaged -$29155.1 across 5 years, with a median of -$3000.0 in 2020.
- Annual changes were most pronounced in 2021 — Change in Inventory surged 600.0% — and 2023, when it sank 1700.0%.
- Avalo Therapeutics' Change in Inventory stood at $68294.0 in 2019, then plunged by 108.79% to -$6000.0 in 2020, then surged by 466.67% to $22000.0 in 2021, then plunged by 109.09% to -$2000.0 in 2022, then sank by 800.0% to -$18000.0 in 2023.
- The last three Change in Inventory figures came in at -$18000.0 (Q3 2023), -$1000.0 (Q2 2023), and -$1000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -18,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |